Biogen Inc (BIIB)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Results
download Want to compare other data? Select Fields| Symbol | BIIB | AMGN | GILD | CELG | VRTX |
| Company | Biogen Inc | Amgen Inc | Gilead Sciences Inc | Celgene Corp | Vertex Pharmaceutic |
| Price Information | |||||
| Exchange | NASDAQ | NASDAQ | NASDAQ | NASDAQ | NASDAQ |
| Open | 221.52 | 301.75 | 65.77 | 108.01 | 406.42 |
| High | 221.98 | 302.91 | 65.77 | 108.59 | 415.67 |
| Low | 216.08 | 298.51 | 65.77 | 107.27 | 394.03 |
| Last | 218.92 | 300.30 | 65.77 | 108.24 | 410.24 |
| Change | -2.50 | +0.82 | +0.31 | +0.11 | +7.74 |
| % Change | -1.13% | +0.27% | +0.47% | +0.10% | +1.92% |
| Volume | 1,156,500 | 2,452,200 | 7,039 | 191,230,496 | 1,614,000 |
| 20-Day Average Volume | 1,377,420 | 2,824,205 | 7,207,057 | 16,188,930 | 1,102,530 |
| Previous Close | 221.42 | 299.48 | 65.46 | 108.13 | 402.50 |
| Industry | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical |
| Has Options | Yes | Yes | Yes | No | Yes |
| Technicals | |||||
| 20-Day Moving Average | 204.54 | 275.28 | 66.35 | 108.17 | 398.63 |
| 20-Day Raw Stochastic | 89.44% | 63.99% | 30.67% | 63.25% | 77.98% |
| 20-Day Relative Strength | 56.77% | 63.04% | 36.34% | 64.69% | 54.47% |
| Weighted Alpha | -27.18 | +28.12 | -19.61 | +46.30 | +17.96 |
| Today's Opinion | 56% Sell | 40% Buy | 100% Sell | 100% Buy | 32% Buy |
| Previous Opinion | 56% Sell | 24% Buy | 100% Sell | 100% Buy | 8% Buy |
| Last Month's Opinion | 100% Sell | 24% Sell | 100% Sell | 100% Buy | 24% Buy |
| Performance | |||||
| 5-Days | |||||
| %Chg | +1.91% since 04/30/24 | +9.62% since 04/30/24 | +0.40% since 05/01/24 | -1.97% since 11/13/19 | +4.44% since 04/30/24 |
| Low | 213.11 on 05/03/24 | 273.38 on 05/01/24 | 64.33 on 05/03/24 | 107.27 on 11/20/19 | 392.47 on 05/01/24 |
| High | 222.40 on 05/06/24 | 322.60 on 05/03/24 | 66.14 on 05/07/24 | 110.53 on 11/14/19 | 415.67 on 05/07/24 |
| 1-Month | |||||
| %Chg | +7.38% since 04/05/24 | +11.24% since 04/05/24 | -5.26% since 04/08/24 | +5.14% since 10/18/19 | +0.88% since 04/05/24 |
| Low | 189.44 on 04/19/24 | 260.68 on 04/19/24 | 64.33 on 05/03/24 | 102.40 on 10/21/19 | 391.01 on 04/18/24 |
| High | 222.40 on 05/06/24 | 322.60 on 05/03/24 | 69.95 on 04/09/24 | 110.70 on 11/13/19 | 415.67 on 05/07/24 |
| 3-Month | |||||
| %Chg | -8.99% since 02/07/24 | +1.50% since 02/07/24 | -10.88% since 02/08/24 | +13.63% since 08/20/19 | -2.11% since 02/07/24 |
| Low | 189.44 on 04/19/24 | 260.68 on 04/19/24 | 64.33 on 05/03/24 | 93.41 on 08/23/19 | 391.01 on 04/18/24 |
| High | 244.95 on 02/12/24 | 322.60 on 05/03/24 | 76.21 on 03/11/24 | 110.70 on 11/13/19 | 437.00 on 02/27/24 |
| 6-Month | |||||
| %Chg | -10.87% since 11/07/23 | +10.77% since 11/07/23 | -15.57% since 11/08/23 | +14.14% since 05/20/19 | +8.46% since 11/07/23 |
| Low | 189.44 on 04/19/24 | 260.52 on 11/21/23 | 64.33 on 05/03/24 | 89.08 on 07/23/19 | 341.90 on 11/16/23 |
| High | 268.30 on 01/03/24 | 329.72 on 02/05/24 | 87.86 on 01/19/24 | 110.70 on 11/13/19 | 448.40 on 01/30/24 |
| Key Statistics | |||||
| Market Capitalization, $K | 31,874,096 | 161,091,424 | 81,502,736 | 77,035,920 | 106,030,224 |
| Shares Outstanding, K | 145,597 | 536,435 | 1,245,077 | 711,714 | 258,459 |
| Annual Sales | 9,835,600,000 | 28,190,000,000 | 27,116,000,000 | 15,281,000,000 | 9,869,200,000 |
| Annual Net Income | 1,161,100,000 | 6,717,000,000 | 5,665,000,000 | 4,046,000,000 | 3,619,600,000 |
| Last Quarter Sales | 2,290,500,000 | 7,447,000,000 | 6,686,000,000 | 4,520,000,000 | 2,517,700,000 |
| Last Quarter Net Income | 393,400,000 | -113,000,000 | -4,170,000,000 | 1,691,000,000 | 968,800,000 |
| 60-Month Beta | -0.01 | 0.60 | 0.22 | 1.41 | 0.39 |
| Per-Share Information | |||||
| Most Recent Earnings | 3.67 on 04/24/24 | 3.96 on 05/02/24 | -1.32 on 04/25/24 | 2.99 on 10/31/19 | 4.76 on 05/06/24 |
| Latest Earnings Date | 04/24/24 | 05/02/24 | 04/25/24 | 10/31/19 | 05/06/24 |
| Most Recent Dividend | N/A | 2.250 on 02/15/24 | 0.770 on 03/14/24 | N/A | N/A |
| Next Ex-Dividends Date | N/A | 05/16/24 | 06/14/24 | N/A | N/A |
| Ratios | |||||
| Price/Earnings ttm | 14.76 | 16.08 | 16.26 | 10.99 | 26.73 |